Antibody-based vaccine strategies against intracellular pathogens

A Casadevall - Current opinion in immunology, 2018 - Elsevier
Current opinion in immunology, 2018Elsevier
Highlights•Antibody can protect against bacterial, fungal and protozoal intracellular
pathogens.•Vaccines that protect against bacterial intracellular pathogens are
available.•Antibody protection against intracellular pathogens relies on diverse
mechanisms.Historically, antibody-mediated immunity was considered effective against
toxins, extracellular pathogens and viruses, while control of intracellular pathogens was the
domain of cellular immunity. However, numerous observations in recent decades have …
Highlights
  • Antibody can protect against bacterial, fungal and protozoal intracellular pathogens.
  • Vaccines that protect against bacterial intracellular pathogens are available.
  • Antibody protection against intracellular pathogens relies on diverse mechanisms.
Historically, antibody-mediated immunity was considered effective against toxins, extracellular pathogens and viruses, while control of intracellular pathogens was the domain of cellular immunity. However, numerous observations in recent decades have conclusively shown that antibody can protect against intracellular pathogens. This paradigmatic shift has tremendous implications for immunology and vaccine design. For immunology the observation that antibody can protect against intracellular pathogens has led to the discovery of new mechanisms of antibody action. For vaccine design the knowledge that humoral immunity can be effective in protection means that the knowledge acquired in more than a century of antibody studies can be applied to make new vaccines against this class of pathogens.
Elsevier